These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 728892

  • 21. Restoration of immune response by levamisole in B-77 virus induced tumor-bearing rats.
    Kalafut F, Kusenda J, Novotná L, Klobusická M.
    Neoplasma; 1988; 35(4):369-78. PubMed ID: 2847064
    [Abstract] [Full Text] [Related]

  • 22. The effect of levamisole on cellular immunity in multiple sclerosis.
    Dau PC, Johnson KP, Spitler LE.
    Clin Exp Immunol; 1976 Nov; 26(2):302-9. PubMed ID: 991460
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Pharmacological and immunotherapeutic properties of levamisole (a review of the literature)].
    Sakharchuk II, Skakal'skaia LM.
    Vrach Delo; 1982 Aug; (8):4-8. PubMed ID: 6983185
    [No Abstract] [Full Text] [Related]

  • 27. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
    Inge TH, Hoover SK, Susskind BM, Barrett SK, Bear HD.
    Cancer Res; 1992 Mar 15; 52(6):1386-92. PubMed ID: 1531782
    [Abstract] [Full Text] [Related]

  • 28. Investigating the role of immunomodulation for colon cancer prevention: results of an in vivo dose escalation trial of levamisole with immunologic endpoints.
    Holcombe RF, Milovanovic T, Stewart RM, Brodhag TM.
    Cancer Detect Prev; 2001 Mar 15; 25(2):183-91. PubMed ID: 11341354
    [Abstract] [Full Text] [Related]

  • 29. Levamisole inhibits angiogenesis in vitro and tumor growth in vivo.
    Friis T, Engel AM, Klein BM, Rygaard J, Houen G.
    Angiogenesis; 2005 Mar 15; 8(1):25-34. PubMed ID: 16132615
    [Abstract] [Full Text] [Related]

  • 30. Asbestos related changes in pulmonary and systemic immune responses--early enhancement followed by inhibition.
    Rola-Pleszczynski M, Lemaire I, Sirois P, Massé S, Bégin R.
    Clin Exp Immunol; 1982 Aug 15; 49(2):426-32. PubMed ID: 7127910
    [Abstract] [Full Text] [Related]

  • 31. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
    Huang X, Wong MK, Yi H, Watkins S, Laird AD, Wolf SF, Gorelik E.
    Cancer Res; 2002 Oct 15; 62(20):5727-35. PubMed ID: 12384531
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of tumor growth by L-deprenyl involves neural-immune interactions in rats with spontaneously developing mammary tumors.
    Thyagarajan S, Madden KS, Stevens SY, Felten DL.
    Anticancer Res; 1999 Oct 15; 19(6B):5023-8. PubMed ID: 10697505
    [Abstract] [Full Text] [Related]

  • 33. Effects of dietary conjugated linoleic acid on lymphocyte function and growth of mammary tumors in mice.
    Wong MW, Chew BP, Wong TS, Hosick HL, Boylston TD, Shultz TD.
    Anticancer Res; 1997 Oct 15; 17(2A):987-93. PubMed ID: 9137439
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE, Shibata MA, Shibata E, Moon RC, Anver MR, Kelloff G, Lubet R.
    Cancer Res; 2001 Oct 15; 61(20):7449-55. PubMed ID: 11606379
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma. I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF.
    Fu YX, Watson GA, Kasahara M, Lopez DM.
    J Immunol; 1991 Jan 15; 146(2):783-9. PubMed ID: 1824777
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.